Laura Fernández

ORCID: 0000-0001-8196-9099
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Ear and Head Tumors
  • Salivary Gland Tumors Diagnosis and Treatment
  • Infectious Diseases and Mycology
  • Tracheal and airway disorders
  • Thyroid Cancer Diagnosis and Treatment
  • Health and Medical Education
  • Vascular Anomalies and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • PI3K/AKT/mTOR signaling in cancer
  • Phonetics and Phonology Research
  • Voice and Speech Disorders
  • Early Modern Spanish Literature
  • Glycogen Storage Diseases and Myoclonus
  • Medical research and treatments
  • Thyroid and Parathyroid Surgery
  • Media and Digital Communication
  • Oral Health Pathology and Treatment
  • Medieval Iberian Studies
  • Cardiac tumors and thrombi
  • Vascular Malformations Diagnosis and Treatment
  • Literary and Cultural Studies
  • Dysphagia Assessment and Management
  • Head and Neck Anomalies

Central University Hospital of Asturias
2016-2023

Centro de Investigación Biomédica en Red de Cáncer
2021

Instituto de Investigación Sanitaria del Principado de Asturias
2018-2021

Instituto de Salud Carlos III
2021

Universidad de Oviedo
2013-2021

Universidade de Santiago de Compostela
2012-2013

Complexo Hospitalario Universitario A Coruña
2012

Background: We performed a comparative analysis between an organ-preservation protocol and surgery followed by radiotherapy in patients with locally advanced squamous cell carcinoma of the larynx hypopharynx; Methods: 60 previously untreated who were treated induction chemotherapy chemoradiotherapy responders compared control group up-front surgery. Both groups statistically comparable, according to subsite, TNM (tumor-node-metastasis) stage, age, sex; Results: Mean age was 58 years 92%...

10.3390/cancers13071735 article EN Cancers 2021-04-06

10.1016/j.otoeng.2017.08.005 article ES Acta Otorrinolaringologica (English Edition) 2017-09-01

Poorly differentiated sinonasal carcinomas (PDCs) are tumors that have a poor prognosis despite advances in classical treatment. Predictive and prognostic markers new personalized treatments could improve the oncological outcomes of patients. In this study, we analyzed SOX2 βIII-tubulin as biomarkers therapeutic impacts on these tumors. The cohort included 57 cases PDCs: 36 undifferentiated carcinoma (SNUC) cases, 13 olfactory neuroblastoma (ONB) 8 neuroendocrine (SNEC) cases. Clinical...

10.3390/jpm13101504 article EN Journal of Personalized Medicine 2023-10-18
Coming Soon ...